Akèy › Dyabèt Tip 2 › Ohio › Cincinnati
Etid klinik pou Dyabèt Tip 2 nan Cincinnati, OH
12 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Cincinnati (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
- The Christ Hospital, Cincinnati
- Velocity Clinical Research-Cincinnati-69044, Cincinnati
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Ap rekriteVolontè an sante akeyi
- St Elizabeth Health Care - CRI, Edgewood · 8 mi lwen
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Cincinnati
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
- Velocity Clinical Research - Cincinnati, Blue Ash, Cincinnati
- St. Elizabeth Healthcare, Edgewood · 8 mi lwen
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Ap rekriteFaz 3
- Research Site, Cincinnati
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Ap rekriteFaz 3
- Univ of Cincinnati Med Cent, Cincinnati
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Ap rekriteFaz 3
- Childrens Hospital Medical Center, Cincinnati
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Ap rekriteEtid obsèvasyon
- Cincinnati Children's Hospital, Cincinnati
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Ap rekriteFaz 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL24 etid
- Boston, MA20 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Miami, FL19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- Atlanta, GA17 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
Lòt etid nan Cincinnati
- Kansè Poumon ki pa ti selil35 etid
- Kansè (tout kalite)28 etid
- Kansè nan tete25 etid
- Ensifizyans kadyak24 etid
- Kansè kolorektal21 etid
- Kansè Metastatik20 etid
- Leksemi mieloïd egi20 etid
- Kansè poumon19 etid
- Kansè ovè19 etid
- Obèsite19 etid
- Kansè pwostat18 etid
- Myelom Miltip17 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.